ヨウ素131アイソトープ市場：用途、エンドユーザー、形態、治療手順、患者人口統計別-2025-2030年の世界予測

ヨウ素131アイソトープ市場は、2023年に52億米ドルと評価され、2024年には55億2,000万米ドルに達すると予測され、CAGR 6.48％で成長し、2030年には80億7,000万米ドルになると予測されています。

ヨウ素131は放射性同位元素で、医療用途、特に核医学の診断・治療目的で広く使用されています。組織を選択的に破壊する能力があるため、甲状腺機能亢進症やある種の甲状腺がんなどの甲状腺疾患の治療に役立っています。エネルギー分野では、ヨウ素131は水圧破砕や向流診断のトレーサーとしても使用されています。ヨウ素131の市場は、世界の甲状腺疾患の有病率の増加、核医学に対する認識と導入の高まり、放射性医薬品技術の進歩によって牽引されています。成長の大きな要因となっているのは、ヘルスケア・インフラへの投資の高まりと、甲状腺疾患に罹患しやすい老人人口の拡大です。さらに、低侵襲治療への需要の高まりも市場拡大に寄与しています。最近のビジネスチャンスとしては、標的放射性医薬品治療における技術革新が挙げられ、これによってヨウ素131を他のがん種の治療にも応用できるようになる一方、送達メカニズムを改善することで有効性を高め、副作用を軽減することができます。しかし、厳しい規制の枠組み、高い製造コスト、放射性物質であるがゆえの特殊な取り扱いと廃棄手続きの必要性といった課題は、成長の見通しを妨げる可能性があります。また、サプライチェーンの制約や、生産における一貫した品質基準の必要性からも限界が生じる。市場機会を生かすためには、研究機関と放射性医薬品企業との戦略的協力関係の開拓が重要です。技術革新が必要な分野としては、ヨウ素131の新規担体分子の研究、投与精度の向上、甲状腺関連疾患以外への応用範囲の拡大などが挙げられます。市場はダイナミックであり、急速な技術進歩や進化する治療需要を特徴としています。これらは共に、競争上の優位性と市場浸透を維持するための持続的な研究投資と規制遵守の重要性を強調しています。

市場力学：急速に進化するヨウ素131アイソトープ市場の主要市場インサイトを公開

ヨウ素131アイソトープ市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • ヨウ素131を活用した様々ながんの診断と治療における核医学イメージング技術の採用拡大
  • ヨウ素131の治療利用を促進するためのヘルスケア機関と研究機関の協力関係の強化
  • ヨウ素131アイソトープアプリケーションの腫瘍学以外の医療分野への拡大による市場成長の促進
• 市場抑制要因
  • 発展途上地域におけるヨウ素131応用のための高度医療施設と訓練を受けた専門家の不足
• 市場機会
  • 獣医学および動物の健康におけるヨウ素131アイソトープの潜在的成長の調査
  • 新興市場の甲状腺疾患治療プロトコールにおけるヨウ素131アイソトープの採用評価
  • 革新的な核医学治療におけるヨウ素131同位体の使用の探求
• 市場の課題
  • 代替診断・治療用アイソトープとの競合

ポーターの5つの力：ヨウ素131アイソトープ市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ヨウ素131アイソトープ市場における外部からの影響の把握

外部マクロ環境要因は、ヨウ素131アイソトープ市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ヨウ素131アイソトープ市場における競合情勢の把握

ヨウ素131アイソトープ市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスヨウ素131アイソトープ市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ヨウ素131アイソトープ市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ヨウ素131アイソトープ市場における成功への道筋を描く

ヨウ素131アイソトープ市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品上市、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ヨウ素131を利用した様々ながんの診断と治療における核イメージング技術の採用の増加
    • ヨウ素131の治療的利用を促進するためにヘルスケア機関と調査機関の協力を強化
    • ヨウ素131アイソトープのアプリケーションが腫瘍学を超えて他の医療分野に拡大し、市場の成長を促進
  • 抑制要因
    • 発展途上地域におけるヨウ素131の応用のための高度な医療施設と訓練を受けた専門家の不足
  • 機会
    • 獣医学と動物の健康におけるヨウ素131同位体の潜在的成長の調査
    • 新興市場における甲状腺疾患治療プロトコルにおけるヨウ素131同位体の採用の評価
    • 革新的な核医学治療におけるヨウ素131同位元素の利用の検討
  • 課題
    • 代替診断および治療用同位元素との競合
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ヨウ素131アイソトープ市場：用途別

• 農業
  • 害虫駆除
  • 土壌肥沃度調査
• 産業
  • 診断
  • 放射線治療
• 医学
  • 甲状腺機能亢進症の治療
  • 研究開発
  • 甲状腺がんの治療
• 製薬
  • 放射性医薬品

第7章 ヨウ素131アイソトープ市場：エンドユーザー別

• 農業分野
• 病院と診療所
  • 私立病院
  • 公立病院
• 製薬会社
• 調査機関
  • 学術調査機関
  • 医療調査機関

第8章 ヨウ素131アイソトープ市場：形態別

• カプセル
• ガス
• 液体

第9章 ヨウ素131アイソトープ市場治療手順別

• 放射性ヨウ素アブレーション
• 放射性ヨウ素療法
• 全身スキャン

第10章 ヨウ素131アイソトープ市場患者層別

• 大人
• 小児科

第11章 南北アメリカのヨウ素131アイソトープ市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域のヨウ素131アイソトープ市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカのヨウ素131アイソトープ市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 1. Advanced Accelerator Applications
• 2. Bayer AG
• 3. BRAHMS GmbH
• 4. Canon Medical Systems
• 5. Cardinal Health
• 6. Cardinal Health Nuclear & Precision Health Solutions
• 7. Curium
• 8. Eckert & Ziegler
• 9. GE Healthcare
• 10. IBA Radiopharma Solutions
• 11. Isotopia Molecular Imaging
• 12. Mallinckrodt Pharmaceuticals
• 13. Medtronic
• 14. Nordion
• 15. NorthStar Medical Radioisotopes
• 16. NTP Radioisotopes
• 17. Philips Healthcare
• 18. Siemens Healthineers
• 19. Smiths Medical
• 20. ZymoGenetics

LIST OF FIGURES

• FIGURE 1. IODINE-131 ISOTOPE MARKET RESEARCH PROCESS
• FIGURE 2. IODINE-131 ISOTOPE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. IODINE-131 ISOTOPE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. IODINE-131 ISOTOPE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. IODINE-131 ISOTOPE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. IODINE-131 ISOTOPE MARKET DYNAMICS
• TABLE 7. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PEST CONTROL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY SOIL FERTILITY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY HYPERTHYROIDISM TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY THYROID CANCER TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY RADIOPHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL SECTOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY GAS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY RADIOACTIVE IODINE ABLATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY RADIOACTIVE IODINE THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY WHOLE-BODY SCAN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
• TABLE 48. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 49. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 50. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 51. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 52. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 53. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 54. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 55. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 56. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 57. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
• TABLE 60. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 61. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 62. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 63. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 65. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 66. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 67. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 68. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 69. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
• TABLE 71. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 72. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 73. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 74. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 75. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 76. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 77. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 78. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 79. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 80. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
• TABLE 82. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 83. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 84. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 85. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 87. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 88. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 89. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 90. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 91. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
• TABLE 93. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 94. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 95. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 96. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 98. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 99. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 100. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 101. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 102. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
• TABLE 104. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 105. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 106. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 107. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 108. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 109. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 110. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 111. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 112. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 113. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 114. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
• TABLE 116. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 117. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 118. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 119. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 120. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 121. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 122. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 123. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 124. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 125. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 126. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
• TABLE 128. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 129. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 130. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 131. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 132. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 133. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 134. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 135. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 136. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 137. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
• TABLE 139. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 140. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 141. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 142. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 144. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 145. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 146. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 147. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 148. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
• TABLE 150. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 151. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 152. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 153. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 154. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 155. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 156. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 157. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 158. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 159. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
• TABLE 161. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 162. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 163. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 164. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 165. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 166. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 167. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 168. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 169. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 170. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
• TABLE 172. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 173. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 174. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 175. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 176. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 177. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 178. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 179. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 180. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 181. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
• TABLE 183. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 184. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 185. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 186. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 187. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 188. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 189. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 190. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 191. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 192. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 193. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
• TABLE 194. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 195. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 196. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 197. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 198. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 199. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 200. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 201. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 202. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 203. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 204. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
• TABLE 205. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 206. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 207. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 208. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 209. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 210. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 211. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 212. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 213. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 214. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 215. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
• TABLE 216. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 217. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 218. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 219. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 220. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 221. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 222. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 223. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 224. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 225. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 226. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
• TABLE 227. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 228. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 229. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 230. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 231. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 232. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 233. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 234. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 235. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 236. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 237. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
• TABLE 238. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 239. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 240. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 241. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 242. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 243. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 244. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 245. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 246. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 247. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 248. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
• TABLE 249. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 250. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 251. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 252. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 253. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 254. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 255. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 256. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 257. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 258. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 259. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
• TABLE 260. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 261. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 262. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 263. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 264. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 265. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 266. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 267. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 268. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 269. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 270. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 271. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
• TABLE 272. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 273. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 274. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 275. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 276. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 277. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 278. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 279. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 280. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 281. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 282. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
• TABLE 283. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 284. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 285. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 286. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 287. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 288. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 289. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 290. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 291. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 292. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 293. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
• TABLE 294. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 295. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 296. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 297. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 298. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 299. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 300. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 301. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 302. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 303. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 304. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
• TABLE 305. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 306. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 307. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 308. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 309. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 310. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 311. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 312. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 313. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 314. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 315. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
• TABLE 316. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 317. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 318. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 319. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 320. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 321. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 322. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 323. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 324. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 325. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 326. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
• TABLE 327. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 328. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 329. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 330. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 331. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 332. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 333. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 334. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 335. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 336. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 337. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
• TABLE 338. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
• TABLE 339. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 340. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
• TABLE 341. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 342. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 343. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 344. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 345. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 346. ITALY IODINE-131 ISOTOP

The Iodine-131 Isotope Market was valued at USD 5.20 billion in 2023, expected to reach USD 5.52 billion in 2024, and is projected to grow at a CAGR of 6.48%, to USD 8.07 billion by 2030.

Iodine-131 is a radioactive isotope extensively used in medical applications, particularly for diagnostic and therapeutic purposes in nuclear medicine. It is instrumental in the treatment of thyroid disorders, such as hyperthyroidism and certain types of thyroid cancer due to its ability to destroy tissue selectively. In the energy sector, Iodine-131 is also used as a tracer in hydraulic fracturing and diagnostics of countercurrent flow. The market for Iodine-131 is driven by the increasing prevalence of thyroid disorders globally, rising awareness and adoption of nuclear medicine, and advancements in radiopharmaceutical technology. A significant influencer of growth is the heightened investment in healthcare infrastructure and expanding geriatric population prone to thyroid conditions. Moreover, increasing demand for minimally invasive procedures contributes to the market's expansion. Recent opportunities include innovations in targeted radiopharmaceutical therapies, which can broaden the application of Iodine-131 in treating other cancer types, while improving delivery mechanisms can enhance its effectiveness and reduce side effects. However, challenges like stringent regulatory frameworks, high production costs, and the necessity for specialized handling and disposal procedures due to its radioactive nature can impede growth prospects. Limitations also arise from supply chain constraints and the need for consistent quality standards in production. To capitalize on market opportunities, developing strategic collaborations between research institutions and radiopharmaceutical companies is crucial. Areas ripe for innovation include research into novel carrier molecules for Iodine-131, improving precision in dose delivery, and expanding its application scope beyond thyroid-related conditions. The market is dynamic, characterized by rapid technological advancements and evolving therapeutic demands, which together underscore the importance of sustained research investment and regulatory compliance to maintain competitive advantage and market penetration.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Iodine-131 Isotope Market

The Iodine-131 Isotope Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing adoption of nuclear imaging techniques in the diagnosis and treatment of various cancers leveraging iodine-131
  • Increased collaboration between healthcare institutions and research bodies to advance the therapeutic use of iodine-131
  • Expansion of iodine-131 isotope applications beyond oncology into other medical fields enhancing market growth
• Market Restraints
  • Lack of advanced medical facilities and trained professionals for iodine-131 applications in developing regions
• Market Opportunities
  • Investigating the potential growth of iodine-131 isotopes in veterinary medicine and animal health
  • Evaluating the adoption of iodine-131 isotopes in thyroid disease treatment protocols across emerging markets
  • Exploring the use of iodine-131 isotopes in innovative nuclear medicine therapies
• Market Challenges
  • Competition from alternative diagnostic and therapeutic isotopes

Porter's Five Forces: A Strategic Tool for Navigating the Iodine-131 Isotope Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Iodine-131 Isotope Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Iodine-131 Isotope Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Iodine-131 Isotope Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Iodine-131 Isotope Market

A detailed market share analysis in the Iodine-131 Isotope Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Iodine-131 Isotope Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Iodine-131 Isotope Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Iodine-131 Isotope Market

A strategic analysis of the Iodine-131 Isotope Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Iodine-131 Isotope Market, highlighting leading vendors and their innovative profiles. These include Advanced Accelerator Applications, Bayer AG, BRAHMS GmbH, Canon Medical Systems, Cardinal Health, Cardinal Health Nuclear & Precision Health Solutions, Curium, Eckert & Ziegler, GE Healthcare, IBA Radiopharma Solutions, Isotopia Molecular Imaging, Mallinckrodt Pharmaceuticals, Medtronic, Nordion, NorthStar Medical Radioisotopes, NTP Radioisotopes, Philips Healthcare, Siemens Healthineers, Smiths Medical, and ZymoGenetics.

Market Segmentation & Coverage

This research report categorizes the Iodine-131 Isotope Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Application, market is studied across Agricultural, Industrial, Medical, and Pharmaceutical. The Agricultural is further studied across Pest Control and Soil Fertility Research. The Industrial is further studied across Diagnostics and Radiation Therapy. The Medical is further studied across Hyperthyroidism Treatment, Research and Development, and Thyroid Cancer Treatment. The Pharmaceutical is further studied across Radiopharmaceuticals.
• Based on End User, market is studied across Agricultural Sector, Hospitals and Clinics, Pharmaceutical Companies, and Research Institutes. The Hospitals and Clinics is further studied across Private Hospitals and Public Hospitals. The Research Institutes is further studied across Academic Research Institutes and Medical Research Institutes.
• Based on Form, market is studied across Capsules, Gas, and Liquid.
• Based on Therapeutic Procedures, market is studied across Radioactive Iodine Ablation, Radioactive Iodine Therapy, and Whole-Body Scan.
• Based on Patient Demographics, market is studied across Adults and Pediatrics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing adoption of nuclear imaging techniques in the diagnosis and treatment of various cancers leveraging iodine-131
    • 5.1.1.2. Increased collaboration between healthcare institutions and research bodies to advance the therapeutic use of iodine-131
    • 5.1.1.3. Expansion of iodine-131 isotope applications beyond oncology into other medical fields enhancing market growth
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of advanced medical facilities and trained professionals for iodine-131 applications in developing regions
  • 5.1.3. Opportunities
    • 5.1.3.1. Investigating the potential growth of iodine-131 isotopes in veterinary medicine and animal health
    • 5.1.3.2. Evaluating the adoption of iodine-131 isotopes in thyroid disease treatment protocols across emerging markets
    • 5.1.3.3. Exploring the use of iodine-131 isotopes in innovative nuclear medicine therapies
  • 5.1.4. Challenges
    • 5.1.4.1. Competition from alternative diagnostic and therapeutic isotopes
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Iodine-131 Isotope Market, by Application

• 6.1. Introduction
• 6.2. Agricultural
  • 6.2.1. Pest Control
  • 6.2.2. Soil Fertility Research
• 6.3. Industrial
  • 6.3.1. Diagnostics
  • 6.3.2. Radiation Therapy
• 6.4. Medical
  • 6.4.1. Hyperthyroidism Treatment
  • 6.4.2. Research and Development
  • 6.4.3. Thyroid Cancer Treatment
• 6.5. Pharmaceutical
  • 6.5.1. Radiopharmaceuticals

7. Iodine-131 Isotope Market, by End User

• 7.1. Introduction
• 7.2. Agricultural Sector
• 7.3. Hospitals and Clinics
  • 7.3.1. Private Hospitals
  • 7.3.2. Public Hospitals
• 7.4. Pharmaceutical Companies
• 7.5. Research Institutes
  • 7.5.1. Academic Research Institutes
  • 7.5.2. Medical Research Institutes

8. Iodine-131 Isotope Market, by Form

• 8.1. Introduction
• 8.2. Capsules
• 8.3. Gas
• 8.4. Liquid

9. Iodine-131 Isotope Market, by Therapeutic Procedures

• 9.1. Introduction
• 9.2. Radioactive Iodine Ablation
• 9.3. Radioactive Iodine Therapy
• 9.4. Whole-Body Scan

10. Iodine-131 Isotope Market, by Patient Demographics

• 10.1. Introduction
• 10.2. Adults
• 10.3. Pediatrics

11. Americas Iodine-131 Isotope Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Iodine-131 Isotope Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Iodine-131 Isotope Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Advanced Accelerator Applications
• 2. Bayer AG
• 3. BRAHMS GmbH
• 4. Canon Medical Systems
• 5. Cardinal Health
• 6. Cardinal Health Nuclear & Precision Health Solutions
• 7. Curium
• 8. Eckert & Ziegler
• 9. GE Healthcare
• 10. IBA Radiopharma Solutions
• 11. Isotopia Molecular Imaging
• 12. Mallinckrodt Pharmaceuticals
• 13. Medtronic
• 14. Nordion
• 15. NorthStar Medical Radioisotopes
• 16. NTP Radioisotopes
• 17. Philips Healthcare
• 18. Siemens Healthineers
• 19. Smiths Medical
• 20. ZymoGenetics